Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 26INDUSTRY 5NETWORK 2OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

ibritumomab tiuxetan 1ferric maltol 1Valganciclovir 1Tranexamic Acid 1Tacrolimus 1Sirolimus 1Moxibustion 1Low-Level Light Therapy 1Infliximab 1Bevacizumab 1Alemtuzumab 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Has results × ibritumomab tiuxetan × Clear all
NCT00491491 2020-08-31

Zevalin-beam for Aggressive Lymphoma

Sheba Medical Center

Phase 3 Completed
60 enrolled 12 charts
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡